Literature DB >> 35261468

Esthesioneuroblastoma presenting with orbital signs and ectopic adrenocorticotropic hormone syndrome.

Wesley M Gillette1, Donald Carroll Hubbard2, Jana Nicole Waters1, Adam Stephen Johnson3.   

Abstract

A 23-year-old woman with known nasal polyps and a recent seizure presented with diplopia, proptosis, extraocular motility deficits, and stigmata of Cushing syndrome. Computed tomography showed a left sinonasal mass extending into the left orbit. Laboratory evaluation revealed refractory hypokalemia and significantly elevated adrenocorticotropic hormone. Histopathologic exam confirmed the diagnosis of esthesioneuroblastoma.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Esthesioneuroblastoma; neuroesthesioma; olfactory neuroblastoma; sinonasal tumor

Year:  2021        PMID： 35261468      PMCID： PMC8865228          DOI： 10.1080/08998280.2021.2001260

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  12 in total

Review 1.  Esthesioneuroblastoma.

Authors:  Thomas J Ow; Diana Bell; Michael E Kupferman; Franco Demonte; Ehab Y Hanna
Journal:  Neurosurg Clin N Am       Date:  2013-01       Impact factor: 2.509

Review 2.  Olfactory neuroblastoma.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2009-07-16

Review 3.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

4.  Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.

Authors:  Neeraja Konuthula; Alfred M Iloreta; Brett Miles; Ryan Rhome; Umut Ozbek; Eric M Genden; Marshall Posner; Krzysztof Misiukiewicz; Satish Govindaraj; Raj Shrivastava; Vishal Gupta; Richard L Bakst
Journal:  Head Neck       Date:  2017-08-17       Impact factor: 3.147

5.  Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy.

Authors:  Markus M Fitzek; Allan F Thornton; Marc Varvares; Marek Ancukiewicz; James Mcintyre; Judy Adams; Stanley Rosenthal; Michael Joseph; Philip Amrein
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

6.  Ophthalmic manifestations of esthesioneuroblastoma.

Authors:  S M Rakes; R P Yeatts; R J Campbell
Journal:  Ophthalmology       Date:  1985-12       Impact factor: 12.079

7.  Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.

Authors:  Ling Mao; Yuan-Peng Xia; Yu-Nan Zhou; Ruo-Lian Dai; Xue Yang; Yan-Jun Wang; Shu-Jie Duan; Xian Qiao; Yuan-Wu Mei; Bo Hu
Journal:  Oncology       Date:  2009-09-07       Impact factor: 2.935

8.  Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.

Authors:  Jamie J Van Gompel; Caterina Giannini; Kerry D Olsen; Eric Moore; Manolo Piccirilli; Robert L Foote; Jan C Buckner; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2012-10

9.  Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution's Clinical Experience.

Authors:  Jakob Liermann; Mustafa Syed; Thomas Held; Denise Bernhardt; Peter Plinkert; Christine Jungk; Andreas Unterberg; Stefan Rieken; Jürgen Debus; Klaus Herfarth; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2018-11-20       Impact factor: 6.639

10.  Olfactory neuroblastoma (esthesioneuroblastoma) presenting as ectopic ACTH syndrome: always follow your nose.

Authors:  Karen Decaestecker; Veerle Wijtvliet; Peter Coremans; Nike Van Doninck
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.